Latest Insider Transactions at Edwards Lifesciences Corp (EW)
This section provides a real-time view of insider transactions for Edwards Lifesciences Corp (EW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edwards Lifesciences Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edwards Lifesciences Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 11
2025
|
Annette Bruls CVP, EMEACLA |
SELL
Payment of exercise price or tax liability
|
Direct |
109
-0.76%
|
$8,502
$78.8 P/Share
|
|
Jul 07
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-1.26%
|
$25,308
$76.79 P/Share
|
|
Jun 16
2025
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
8,950
-4.15%
|
$671,250
$75.23 P/Share
|
|
Jun 16
2025
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
8,950
+3.98%
|
$528,050
$59.26 P/Share
|
|
Jun 03
2025
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Indirect |
967
-10.11%
|
$74,459
$77.32 P/Share
|
|
Jun 02
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
2,570
-4.86%
|
$197,890
$77.4 P/Share
|
|
May 30
2025
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Indirect |
16,099
-62.73%
|
$1,239,623
$77.21 P/Share
|
|
May 22
2025
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
1,500
-4.29%
|
$112,500
$75.08 P/Share
|
|
May 16
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
5,815
+18.47%
|
-
|
|
May 16
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
5,815
-6.7%
|
-
|
|
May 13
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
2,771
+12.25%
|
-
|
|
May 13
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
2,771
-3.09%
|
-
|
|
May 11
2025
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,860
-3.09%
|
$208,780
$73.68 P/Share
|
|
May 11
2025
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
988
-0.48%
|
$72,124
$73.68 P/Share
|
|
May 11
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,200
-2.92%
|
$87,600
$73.68 P/Share
|
|
May 11
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-1.02%
|
$19,783
$73.68 P/Share
|
|
May 11
2025
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
580
-1.63%
|
$42,340
$73.68 P/Share
|
|
May 11
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
816
-1.52%
|
$59,568
$73.68 P/Share
|
|
May 09
2025
|
Leslie C. Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+34.89%
|
-
|
|
May 09
2025
|
David T Feinberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+37.68%
|
-
|
|
May 09
2025
|
Kieran Gallahue Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,682
+34.89%
|
-
|
|
May 09
2025
|
Heisz Leslie Stone Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+9.51%
|
-
|
|
May 09
2025
|
Paul A Laviolette Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+19.79%
|
-
|
|
May 09
2025
|
Steven R Loranger Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,682
+3.49%
|
-
|
|
May 09
2025
|
Ramona Sequeira Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+23.19%
|
-
|
|
May 09
2025
|
Nicholas J Valeriani Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,564
+6.56%
|
-
|
|
May 09
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
330
-1.22%
|
$24,420
$74.42 P/Share
|
|
May 09
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
330
+1.21%
|
$14,850
$45.28 P/Share
|
|
May 09
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,250
-21.49%
|
$832,500
$74.4 P/Share
|
|
May 09
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+17.69%
|
$506,250
$45.28 P/Share
|
|
May 08
2025
|
Annette Bruls CVP, EMEACLA |
BUY
Grant, award, or other acquisition
|
Direct |
6,200
+30.27%
|
-
|
|
May 08
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Grant, award, or other acquisition
|
Direct |
4,225
+13.7%
|
-
|
|
May 08
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Grant, award, or other acquisition
|
Direct |
8,375
+13.48%
|
-
|
|
May 08
2025
|
Larry L Wood Global President TAVR & Surg |
BUY
Grant, award, or other acquisition
|
Direct |
11,050
+5.05%
|
-
|
|
May 08
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
4,122
+19.45%
|
-
|
|
May 08
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
4,122
-4.27%
|
-
|
|
May 08
2025
|
Bernard J Zovighian CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,550
+31.09%
|
-
|
|
May 08
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+24.59%
|
-
|
|
May 08
2025
|
Daveen Chopra CVP, TMTT |
BUY
Grant, award, or other acquisition
|
Direct |
9,200
+20.55%
|
-
|
|
May 08
2025
|
Wayne Markowitz GM & SVP, Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
3,350
+21.34%
|
-
|
|
May 08
2025
|
Andrew M. Dahl SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
3,335
+29.15%
|
-
|
|
May 07
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
851
-1.84%
|
$62,974
$74.92 P/Share
|
|
May 07
2025
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
819
-0.41%
|
$60,606
$74.92 P/Share
|
|
May 07
2025
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,253
-7.43%
|
$314,722
$74.92 P/Share
|
|
May 07
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,406
-4.83%
|
$104,044
$74.92 P/Share
|
|
May 07
2025
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
627
-2.32%
|
$46,398
$74.92 P/Share
|
|
May 07
2025
|
Wayne Markowitz GM & SVP, Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-3.23%
|
$22,200
$74.92 P/Share
|
|
May 07
2025
|
Wayne Markowitz GM & SVP, Surgical |
SELL
Open market or private sale
|
Direct |
268
-2.8%
|
$20,100
$75.08 P/Share
|
|
May 06
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
1,036
+7.41%
|
-
|
|
May 06
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
1,036
-1.78%
|
-
|